Anti-IFNAR2 antibody (101-243) (STJ11104355)

SPECIFICATIONS
ClonalityPolyclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
STJ11104355
๐Ÿšš Free UK Delivery on orders over ยฃ150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRabbit polyclonal IFNAR2 (101-243) antibody for use in WB and ELISA in human, mouse and rat samples. Datasheet included with dilution recommendations, and related reagents.
ApplicationsWB/ELISA
HostRabbit
ReactivityHuman/Mouse/Rat
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ClonalityPolyclonal
IsotypeIgG
ConjugationUnconjugated
ConcentrationLot specific
PurificationAffinity purification
Dilution RangeWB:1:500-1:1000
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
FormulationPBS with 0.05% Proclin300, 50% Glycerol, pH 7.3.
Storage InstructionStore at-20ยฐC for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.

Target Information

Gene SymbolIFNAR2
Gene ID3455
Uniprot IDINAR2_HUMAN
Immunogen Region101-243
Immunogen SequenceSTHEAYVTVLEGFSGNTTLF SCSHNFWLAIDMSFEPPEFE IVGFTNHINVMVKFPSIVEE ELQFDLSLVIEEQSEGIVKK HKPEIKGNMSGNFTYIIDKL IPNTNYCVSVYLEHSDEQAV IKSPLKCTLLPPGQESESAE SAK
SpecificityRecombinant fusion protein containing a sequence corresponding to amino acids 101-243 of human IFNAR2 (NP_997468.1).

Additional Info

Tissue Specificity Isoform 3 is detected in the urine (at protein level). Expressed in blood cells. Expressed in lymphoblastoid and fibrosarcoma cell lines.
Post Translational Modifications Phosphorylated on tyrosine residues upon interferon binding. Phosphorylation at Tyr-337 or Tyr-512 are sufficient to mediate interferon dependent activation of STAT1, STAT2 and STAT3 leading to antiproliferative effects on many different cell types. Glycosylated.
Function Together with IFNAR1, forms the heterodimeric receptor for type I interferons (including interferons alpha, beta, epsilon, omega and kappa). Type I interferon binding activates the JAK-STAT signaling cascade, resulting in transcriptional activation or repression of interferon-regulated genes that encode the effectors of the interferon response. Mechanistically, type I interferon-binding brings the IFNAR1 and IFNAR2 subunits into close proximity with one another, driving their associated Janus kinases (JAKs) (TYK2 bound to IFNAR1 and JAK1 bound to IFNAR2) to cross-phosphorylate one another. The activated kinases phosphorylate specific tyrosine residues on the intracellular domains of IFNAR1 and IFNAR2, forming docking sites for the STAT transcription factors (STAT1, STAT2 and STAT). STAT proteins are then phosphorylated by the JAKs, promoting their translocation into the nucleus to regulate expression of interferon-regulated genes. Isoform 3: Potent inhibitor of type I IFN receptor activity.
Protein Name Interferon Alpha/Beta Receptor 2
Ifn-R-2
Ifn-Alpha Binding Protein
Ifn-Alpha/Beta Receptor 2
Interferon Alpha Binding Protein
Type I Interferon Receptor 2
Database Links Reactome: R-HSA-909733 P48551-2
Reactome: R-HSA-912694 P48551-2
Reactome: R-HSA-9679191 P48551-2
Reactome: R-HSA-9705671 P48551-2
Reactome: R-HSA-9833109 P48551-2
Cellular Localisation Isoform 1: Cell Membrane
Single-Pass Type I Membrane Protein
Isoform 2: Cell Membrane
Isoform 3: Secreted
Alternative Antibody Names Anti-Interferon Alpha/Beta Receptor 2 antibody
Anti-Ifn-R-2 antibody
Anti-Ifn-Alpha Binding Protein antibody
Anti-Ifn-Alpha/Beta Receptor 2 antibody
Anti-Interferon Alpha Binding Protein antibody
Anti-Type I Interferon Receptor 2 antibody
Anti-IFNAR2 antibody
Anti-IFNABR antibody
Anti-IFNARB antibody

Information sourced from Uniprot.org

Citations

Product Review